SEC Form 4 · accession 0000899243-17-029155
Coherus Oncology, Inc. · CHRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan C. Herman
Officer — Chief Scientific Officer
Period of report
Dec 15, 2017
Accepted (ET)
Dec 19, 2017 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001512762
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value | Dec 15, 2017 | A | 809 | $0.00 | A | 50,460 | D | |
| Common Stock, $0.0001 par valueF1 | holding | — | — | — | 300,164 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are held by the Herman Trust, dated March 16, 2001, of which Reporting Person is a co trustee.